Delivery Order SPE2DB22D2007-SPE2DB25FJ1FS
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,111.66 firm fixed-price delivery order is for the supply of the medication RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of April 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $19,587.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S, with a Firm Fixed Price and an ultimate completion date of May 6, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $51,407.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product. It is a firm fixed-price, delivery order contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside and was openly competed. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $9,768.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp maintains a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,693.60, is for the delivery of the medication RINVOQ ER 30 MG TABLET UU 30S. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,202.34 firm fixed-price delivery order contract is for the supply of the prescription medication RINVOQ ER 45 MG TABLET. The contract has an ultimate completion date of April 8, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $37,413.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication RINVOQ ER 15 MG TABLET, a non-set-aside award with a firm fixed price. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,592.65, is a delivery order for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999, which provides a...
This federal contract award, valued at $12,827.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RINVOQ ER 15 MG TABLET, a medication used to treat certain medical conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. The contract is not set aside and is open to full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,444.10 delivery order is a firm fixed-price contract for the supply of the prescription medication RINVOQ ER 30 MG TABLET UU 30S. The contract has a completion date of May 6, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a significant...